Motus Gi Holdings Inc Asset Turnover Ratio (MOTS), as of first quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Motus Gi Holdings Inc   (MOTS)
 

Motus Gi Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Motus Gi Holdings Inc asset turnover ratio, the ability of Motus Gi Holdings Inc 's assets to generate revenue in the first quarter 2024, increased sequentially to 0.04 in the first quarter (Mar 31 2024), yet the ratio remained below the average, as MOTS's position remain challenging.

Within sector 175 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2024 compared to the preceding quarter from 0 to 3369.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MOTS Asset Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Asset Change -42.23 % -59.07 % -39.82 % -41.53 % -49.92 %
Y / Y Revenue Change 14.29 % -41.28 % -69.06 % -38.92 % 180 %
Asset Turnover Ratio (TTM) 0.04 0.03 0.03 0.04 0.04
MOTS's Total Ranking # 3369 # 0 # 2475 # 2483 #
Seq. Asset Change -2.17 % -30.89 % -10.99 % -4.01 % -30.69 %
Seq. Revenue Change 0 % -25.58 % -23.89 % 101.79 % -48.62 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 176
Healthcare Sector # 507
Overall Market # 3369

Asset Turnover Ratio Statistics
High Average Low
7.42 4.43 1.71
(Dec 31 2022)   (Sep 30 2019)




MOTS Company Profile • Back to MOTS Efficiency Comparisons • Compare MOTS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Curis Inc   0.13 $ 9.812  Millions$ 78.397  Millions
Asensus Surgical Inc   0.12 $ 7.725  Millions$ 62.250  Millions
Kymera Therapeutics Inc   0.12 $ 79.413  Millions$ 644.583  Millions
Inspiremd Inc   0.12 $ 5.860  Millions$ 48.332  Millions
Biocardia Inc   0.12 $ 0.468  Millions$ 3.951  Millions
Cartesian Therapeutics Inc   0.12 $ 25.906  Millions$ 218.949  Millions
2seventy Bio Inc   0.12 $ 71.201  Millions$ 605.749  Millions
Aligos Therapeutics Inc   0.12 $ 13.792  Millions$ 117.853  Millions
Liquidia Corporation  0.12 $ 15.967  Millions$ 137.172  Millions
Verrica Pharmaceuticals Inc   0.12 $ 8.913  Millions$ 76.813  Millions
Skinvisible Inc   0.11 $ 0.020  Millions$ 0.174  Millions
Foghorn Therapeutics Inc   0.11 $ 33.896  Millions$ 298.480  Millions
Pacific Biosciences Of California Inc   0.11 $ 199.162  Millions$ 1,790.480  Millions
Ginkgo Bioworks Holdings Inc   0.11 $ 208.697  Millions$ 1,891.374  Millions
Cue Biopharma Inc   0.11 $ 7.020  Millions$ 64.383  Millions
Hcw Biologics Inc   0.11 $ 3.645  Millions$ 33.510  Millions
Vbi Vaccines Inc  0.11 $ 9.411  Millions$ 87.875  Millions
Dermtech Inc   0.11 $ 13.817  Millions$ 129.968  Millions
Biocorrx Inc   0.10 $ 0.052  Millions$ 0.499  Millions
Arbutus Biopharma Corp  0.10 $ 12.986  Millions$ 126.560  Millions
Sage Therapeutics Inc   0.10 $ 91.063  Millions$ 920.457  Millions
Hyperfine Inc   0.10 $ 9.608  Millions$ 98.828  Millions
Zomedica Corp   0.10 $ 24.953  Millions$ 261.682  Millions
Ocugen Inc   0.09 $ 6.607  Millions$ 70.001  Millions
Abeona Therapeutics Inc   0.09 $ 6.096  Millions$ 64.617  Millions
Spruce Biosciences Inc   0.09 $ 10.127  Millions$ 107.608  Millions
Taysha Gene Therapies Inc   0.09 $ 14.156  Millions$ 150.761  Millions
Tango Therapeutics Inc   0.09 $ 37.232  Millions$ 404.077  Millions
Werewolf Therapeutics Inc   0.09 $ 16.221  Millions$ 178.514  Millions
Igc Pharma Inc   0.09 $ 1.345  Millions$ 14.815  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.